Compare · BIOX vs CLXT
BIOX vs CLXT
Side-by-side comparison of Bioceres Crop Solutions Corp. (BIOX) and Calyxt Inc. (CLXT): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BIOX and CLXT operate in Agricultural Chemicals (Industrials), so they compete in similar markets.
- BIOX is the larger of the two at $502.3M, about 8.1x CLXT ($62.0M).
- BIOX has hit the wire 1 time in the past 4 weeks while CLXT has been quiet.
- BIOX has more recent analyst coverage (7 ratings vs 2 for CLXT).
- Company
- Bioceres Crop Solutions Corp.
- Calyxt Inc.
- Price
- -
- -
- Market cap
- $502.3M
- $62.0M
- 1M return
- -14.20%
- -
- 1Y return
- -91.35%
- -
- Industry
- Agricultural Chemicals
- Agricultural Chemicals
- Exchange
- AMEX
- NASDAQ
- IPO
- 2017
- News (4w)
- 1
- 0
- Recent ratings
- 7
- 2
Bioceres Crop Solutions Corp.
Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. The company operates through three segments: Seed and Integrated Products, Crop Protection, and Crop Nutrition. The Seed and Integrated Products segment develops and commercializes seed technology, biotechnological events, germplasm, and seed treatments. The Crop Protection segment develops, produces, and markets adjuvants, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. In addition, the company offers HB4, a drought tolerant seed technology program. It operates in Argentina, Austria, Bolivia, Brazil, Lebanon, the United States, Italy, Paraguay, the United Kingdom, South Africa, France, Canada, Ukraine, Uruguay, and internationally. The company is headquartered in Rosario, Argentina. Bioceres Crop Solutions Corp. is a subsidiary of Bioceres LLC.
Calyxt Inc.
Calyxt, Inc., a technology company, focuses on delivering plant-based solutions in the United States. It engages in the development of improved digestibility alfalfa; high fiber wheat; high oleic low linolenic soybeans; winter oats; hemp; fat soybeans; and cold storable potatoes. As of March 4, 2021, the company had nine projects at Phase I stage or later in development across alfalfa, hemp, oats, soybeans, and wheat. Calyxt, Inc. has a research collaboration with NRGene, which includes the adoption of NRGene's cloud-based genomics platform to support various research projects; and a commercialization agreement with S&W Seed Company for the exclusive license of an improved quality alfalfa seed in the United States and various geographies outside the United States. The company was formerly known as Cellectis Plant Sciences, Inc. and changed its name to Calyxt, Inc. in May 2015. Calyxt, Inc. was incorporated in 2010 and is headquartered in Roseville, Minnesota. Calyxt, Inc. is a subsidiary of Cellectis S.A.
Latest BIOX
- SEC Form 6-K filed by Bioceres Crop Solutions Corp.
- SEC Form 3 filed by new insider Duraiswami Narain
- SEC Form 6-K filed by Bioceres Crop Solutions Corp.
- Amendment: SEC Form 3 filed by new insider Simmermacher Ezequiel
- New insider Mago Yogesh claimed ownership of 55,399 units of Ordinary Shares (SEC Form 3)
- Bioceres Crop Solutions Reports Fiscal Third Quarter 2026 Financial and Operational Results
- New insider Trucco Federico claimed ownership of 356,000 units of Ordinary Shares (SEC Form 3)
- CORRECTING and REPLACING Bioceres Crop Solutions to Host Fiscal Third Quarter 2026 Financial Results Conference Call on Tuesday, May 12, 2026 at 8:30 a.m. Eastern Time
- Bioceres Crop Solutions to Host Fiscal Third Quarter 2026 Financial Results Conference Call on Tuesday, May 12, 2026 at 8:30 a.m. Eastern Time
- SEC Form 3 filed by new insider Roque Jose Augusto
Latest CLXT
- Totus Medicines Appoints Simon Harnest, MSc, BSc, as Chief Financial Officer
- SEC Form SC 13G/A filed by Calyxt Inc. (Amendment)
- Calyxt Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
- Riggs Rory B converted options into 1,500,000 shares and acquired 1,505,967 units of Class B Common Stock, increasing direct ownership by 128% to 3,103,788 units (SEC Form 4)
- Calyxt Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
- SEC Form 424B5 filed by Calyxt Inc.
- Calyxt Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
- Riggs Rory B disposed of 39,476 shares and bought $5,470,992 worth of shares (517,107 units at $10.58), increasing direct ownership by 47% to 1,622,495 units (SEC Form 4)
- Calyxt Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- SEC Form 424B5 filed by Calyxt Inc.